跳至主要内容
临床试验/NCT06607731
NCT06607731招募中不适用

Percutaneous Gelled Alcohol Sclerotherapy for Aggressive Angiomas: Evaluation of Feasibility, Safety, and Efficacy

Centre Hospitalier Universitaire de Saint Etienne1 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2024年6月25日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
11
试验地点
1
主要终点
Number of complications identified in data collection

研究概览

简要总结

The investigators aimed to evaluate efficacy and safety of a non-surgical protocol treatment combining transarterial embolization and percutaneous radiopaque gelled ethanol (RGE) sclerotherapy in a first procedure, then followed by vertebroplasty in a second procedure, to treat aggressive vertebral hemangioma patients in tertiary hospital. Exclusion criteria were age <18-years old and any association with neurological deficit.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Every patients treated by gelled alcohol sclerotherapy for aggressive angiomas, in the University Hospital of Saint-Etienne.

排除标准

  • Patients no treated by gelled alcohol sclerotherapy.

结局指标

主要结局

Number of complications identified in data collection

时间窗: Day 1

Number of complications identified in data collection

次要结局

  • Number of lesion identified in data collection(Day 1)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Percutaneous Gelled Alcohol Sclerotherapy for... | 临床试验